KAISHA Packaging achieves record of supplying seals for 2 billion doses of COVID vaccines globally

Leading pharma-packaging firm, KAISHA Packaging, has accomplished new heights in the fight against COVID-19. The company has successfully provided over 2 billion doses worth of flip-top aluminium seals used for packaging COVID vaccines. The seal is used as closures for injection vials during the vaccination drive and is as such an essential part of the vaccine package ensuring tamper-proof delivery.  This is especially relevant for fulfilling India and the world’s current vaccination drive, especially given the need for successive booster doses considering the ever-changing nature of COVID.  

KAISHA Packaging has been a constant and biggest supplier for these seals to all the vaccines available in the Indian market and abroad. To ensure a consistent supply of vaccines and plug any shortages or gaps, the company managed to arrange and stock an extremely large volume of raw material. Not only did KAISHA Packaging successfully manage this challenge, it also expanded its capacity by over 450 million pieces to reach the overall capacity of 1.2 billion  pieces per annum over the past year, which was unprecedented.  

Rishad Dadachanji, Director, KAISHA Group of Companies, shared, “This is a testimonial of our commitment to support India’s vaccine drive and developers with the best packaging solutions. As a pharma allied sector company, we have worked hard to ensure no gaps remain in our supply chain to ensure a consistent supply of vaccine seals. We are proud to have provided seals for over 2 billion vaccine doses so far. Under the current circumstances of ambiguity around the COVID pandemic, Kaisha is well-prepared to rise up to any supply challenges.” 

KAISHA packaging was established as a premium manufacturer of pharmaceutical closure systems for vials as well as speciality plastics for pharmaceutical use in 2003. The company has since revolutionized the way that aluminium seals are manufactured in India.  

The company is part of the larger (Dadachanji Group), headquartered in Mumbai, India. It is a diversified group with business interests that include Pharmaceuticals and Biotechnology, Primary and Secondary Packaging, Medical Devices, Machine Building, Automation and Robotics. The group previously also owned a part of the Indo-German Venture SCHOTT-Kaisha, which is the largest supplier of vaccine vials in the country. 



It is a premium manufacturer of a large variety of aluminium seals for injection vials and plastic articles for the pharmaceutical industry. With a focus of not only offering high quality closures at affordable prices, KAISHA also offers several custom-made solutions that can be developed in-house for the ever-evolving pharmaceutical industry. They were the first company in India to manufacture aluminium seals in controlled environments under positive pressure, while adopting several other pharma practices, such as GDP, PU flooring, HVAC systems, segregated man and material entry, linear material flow and EHS polices amongst other positives.